The Current and Promising Oral Delivery Methods for Protein- and Peptide-Based Drugs

被引:11
|
作者
Nicze, Michal [1 ]
Borowka, Maciej [1 ]
Dec, Adrianna [1 ]
Niemiec, Aleksandra [1 ]
Buldak, Lukasz [1 ]
Okopien, Boguslaw [1 ]
机构
[1] Med Univ Silesia, Fac Med Sci, Dept Internal Med & Clin Pharmacol, Medykow 18, PL-40752 Katowice, Poland
关键词
peptide- and protein-based drug; oral drug absorption; permeation enhancers; hydrogels; microneedles; semaglutide; octreotide; desmopressin; cyclosporine; CELL-PENETRATING PEPTIDES; CYCLOSPORINE-A; IN-VITRO; CARDIOVASCULAR OUTCOMES; GASTROINTESTINAL MUCUS; INTESTINAL-ABSORPTION; TRYPSIN-INHIBITOR; TIGHT JUNCTIONS; HUMAN INSULIN; NANOPARTICLES;
D O I
10.3390/ijms25020815
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Drugs based on peptides and proteins (PPs) have been widely used in medicine, beginning with insulin therapy in patients with diabetes mellitus over a century ago. Although the oral route of drug administration is the preferred one by the vast majority of patients and improves compliance, medications of this kind due to their specific chemical structure are typically delivered parenterally, which ensures optimal bioavailability. In order to overcome issues connected with oral absorption of PPs such as their instability depending on digestive enzymes and pH changes in the gastrointestinal (GI) system on the one hand, but also their limited permeability across physiological barriers (mucus and epithelium) on the other hand, scientists have been strenuously searching for novel delivery methods enabling peptide and protein drugs (PPDs) to be administered enterally. These include utilization of different nanoparticles, transport channels, substances enhancing permeation, chemical modifications, hydrogels, microneedles, microemulsion, proteolytic enzyme inhibitors, and cell-penetrating peptides, all of which are extensively discussed in this review. Furthermore, this article highlights oral PP therapeutics both previously used in therapy and currently available on the medical market.
引用
收藏
页数:29
相关论文
共 50 条
  • [11] Preparation and characterization of BSA as a model protein loaded chitosan nanoparticles for the development of protein-/peptide-based drug delivery system
    Yadav, Preeti
    Yadav, Awadh Bihari
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 7 (01)
  • [12] Nanoparticles: Oral Delivery for Protein and Peptide Drugs
    Shu-jun Cao
    Shuo Xu
    Hui-ming Wang
    Yong Ling
    Jiahua Dong
    Rui-dong Xia
    Xiang-hong Sun
    AAPS PharmSciTech, 20
  • [13] A Review of Protein- and Peptide-Based Chemical Conjugates: Past, Present, and Future
    Holz, Emily
    Darwish, Martine
    Tesar, Devin B.
    Shatz-Binder, Whitney
    PHARMACEUTICS, 2023, 15 (02)
  • [14] Recombinant Protein- and Synthetic Peptide-Based Immunoblot Test for Diagnosis of Neurocysticercosis
    Noh, John
    Rodriguez, Silvia
    Lee, Yeuk-Mui
    Handali, Sukwan
    Gonzalez, Armando E.
    Gilman, Robert H.
    Tsang, Victor C. W.
    Garcia, Hector H.
    Wilkins, Patricia P.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2014, 52 (05) : 1429 - 1434
  • [15] Current state of the art in peptide-based gene delivery
    Hadianamrei, Roja
    Zhao, Xiubo
    JOURNAL OF CONTROLLED RELEASE, 2022, 343 : 600 - 619
  • [16] Current state of the art in peptide-based gene delivery
    Hadianamrei, Roja
    Zhao, Xiubo
    Journal of Controlled Release, 2022, 343 : 600 - 619
  • [17] Liposomes for oral delivery of protein and peptide-based therapeutics: challenges, formulation strategies, and advances
    Jash, Apratim
    Ubeyitogullari, Ali
    Rizvi, Syed S. H.
    JOURNAL OF MATERIALS CHEMISTRY B, 2021, 9 (24) : 4773 - 4792
  • [18] Recent Advances in the Development of Protein- and Peptide-Based Subunit Vaccines against Tuberculosis
    Bellini, Chiara
    Horvati, Kata
    CELLS, 2020, 9 (12) : 1 - 16
  • [19] Insights into current directions of protein and peptide-based hydrogel drug delivery systems for inflammation
    X. Janet Bertilla
    S. Rupachandra
    Polymer Bulletin, 2023, 80 : 9409 - 9436
  • [20] Protein- and Peptide-Based Virus Inactivators: Inactivating Viruses Before Their Entry Into Cells
    Su, Xiaojie
    Wang, Qian
    Wen, Yumei
    Jiang, Shibo
    Lu, Lu
    FRONTIERS IN MICROBIOLOGY, 2020, 11